论文部分内容阅读
虽然卵巢癌仅占女性恶性肿瘤的5%,但在美国卵巢癌在女性癌肿死亡中占第四位。美国每年约有14000人发病,且其发生率在上升中。由于目前尚无早期发现本病的方法,故到诊断时约有半数病灶已越出盆腔范围,这种病人用手术及放疗已不能控制病情发展,宜采取化学治疗。近年来对Ⅲ期和Ⅳ期卵巢癌采用联合化疗的疗效比单剂化疗佳。烷化剂则是癌肿缓解的主要药物。近十年来一年生存率
Although ovarian cancer accounts for only 5% of female malignancies, ovarian cancer in the United States ranks fourth among female cancer cancers. In the United States, about 14,000 people are affected each year, and its incidence is on the rise. Because there is no early detection of the disease, it is estimated that about half of the lesions have been out of the pelvic area, this patient surgery and radiotherapy have been unable to control the progression of the disease, should take the chemical treatment. In recent years, the efficacy of combined chemotherapy for stage Ⅲ and Ⅳ ovarian cancer is better than that of single-dose chemotherapy. Alkylating agent is the main drug for cancer remission. One year survival rate in the past ten years